Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer

BACKGROUND: To evaluate whether the addition of bevacizumab (BVZ) to capecitabine-based chemoradiotherapy in the preoperative treatment of locally advanced rectal cancer (LARC) improves efficacy measured by the pathological complete response (pCR) rate. METHODS: A phase II two-step design was perfor...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Cancer
Glavni autori: García, Margarita, Martinez-Villacampa, Mercedes, Santos, Cristina, Navarro, Valentin, Teule, Alex, Losa, Ferran, Pisa, Aleydis, Cambray, Maria, Soler, Gemma, Lema, Laura, Kreisler, Esther, Figueras, Agnes, Juan, Xavier San, Viñals, Francesc, Biondo, Sebastiano, Salazar, Ramon
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4342871/
https://ncbi.nlm.nih.gov/pubmed/25886275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1052-0
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items